Washington Cancer Institute Program in Peritoneal Surface Malignancy

Washington, DC, United States

Washington Cancer Institute Program in Peritoneal Surface Malignancy

Washington, DC, United States

Time filter

Source Type

Halkia E.,Metaxa Cancer Memorial Hospital | Spiliotis J.,Metaxa Cancer Memorial Hospital | Sugarbaker P.,Washington Cancer Institute Program in Peritoneal Surface Malignancy
Gastroenterology Research and Practice | Year: 2012

The management and the outcome of peritoneal metastases or recurrence from epithelial ovarian cancer are presented. The biology and the diagnostic tools of EOC peritoneal metastasis with a comprehensive approach and the most recent literatures data are discussed. The definition and the role of surgery and chemotherapy are presented in order to focuse on the controversial points. Finally, the paper discusses the new data about the introduction of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced epithelial ovarian cancer. Copyright © 2012 Evgenia Halkia et al.

Loading Washington Cancer Institute Program in Peritoneal Surface Malignancy collaborators
Loading Washington Cancer Institute Program in Peritoneal Surface Malignancy collaborators